glp 1 drugs and fatty liver

glp 1 drugs and fatty liver GLP-1 Receptor Agonists in Non-Alcoholic Disease: Current Evidence Future Perspectives Efficacy and safety of anti-obesity

Name: glp 1 drugs and fatty liver GLP-1 Receptor Agonists in Non-Alcoholic Disease: Current Evidence Future Perspectives Efficacy and safety of anti-obesity
Brand: 2m-capital.com
SKU: 70989946293
Price: 23.85 USD
Availability: InStock
Rating: 4.2673000000000005 (16 reviews)

SKU: 70989946293

4.3

EUR23.85 EUR51.85

Pay in 4 interest-free payments of $5.96 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 24 - Sep 29

Description

Data from randomized controlled trials suggest that withdrawing either glucagon-like peptide-1 (GLP-1) receptor agonists or dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonists leads to a substantial regain of lost weight

Acknowledgements The cytogenetic and statistical analysis was performed in Department of Molecular Biology and Genetics at Burdur Mehmet Akif Ersoy University

4 Pedersen CF, Eiskjr S, Andersen M, Carreon LY, Doering P